1Surowiak P,Materna V,Matkowski R,et al.Relationship between the expression of cyclooxygenase 2 and MDR1/Pglycoprotein in invasive breast cancers and their prognostic significance[J].Breast Cancer Res,2005,7(8):862-870.
2Chou FP,Chu YC,Hsu JD,et al.Specific induction of glu tathione S-transferase GSTM2 subunit expression by epigallocatechin gallate in rat liver[J].Biochem Pharmacol,2000,60(7):643-650.
1Lehnet M, Clinical multidrugresistance resistance in cancer: a multi factorial problem. Eur J Cancer, 1996,32A:912-920.
2Norris MD, Bordow SB and Marshall GM. Expression of the gene for multidrugresistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med,1996,334,231-238.
3Sugawara H, Yamada H, Nakamyra H, et al. Prefential expression of the Multidrugresistace associated protein MRP in adenocarcinoma of the lung. Int J Cancer , 1995,64:322-325.
4Cole SPC, Bhardaj G, Gerlach JH, et al. Overexpression of a transporter gene in amultidrug-resistant human lung cancer cell line. Science, 1992, 258:1650-1 654.
5Lacave R, Coulet F, Riccl S, et al. Comparative evaluation by semiquanantita tivereverse transcriptae polymerase chain reaction of MDR1, MRP and GSTp gene expression inbreast carcinomas. Br J Cancer, 1988, 77:694-702.
6Nooter K, Brutel de la Rivier G, Look MP, et al. The prognostic significance ofexpression of the multidrug resistance-associated protein(MRP) in primary br east cancer.Br J Cancer, 1997, 76: 486-493.
7Beck J, Bohnet B, Brugger D, et al. Multiple gene expression analysis reveralsdistinct difference between G2 and G3 stage breast cancers, and correlation of PKC with MDR1, MRP and LRP gene expression. Br J Cancer, 1998, 77:87-91.
8Filipits M., Malayeri R., Suchomel R., et al. Expression of the multidrugresistance rpotein (MRP) in breast cancer. Anticancer Res, 1999,19:5047-5050.
